Find the latest pharmaceutical market place for formulations enquiry about Cycloserine on PharmaCompass.com.

Various Finished Dosage Formulations needed in Iran [ENA11303]

A privately owned healthcare and pharmaceutical company focused on the development and commercialization of a portfolio of products and services within the areas of aesthetics, dermatology, medical food supplement and tech transfer is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The suppliers must support this enquiry with CTD Dossiers.
1. Cycloserine (250 mg) Capsules
2. Dalteparin Sodium (25000 IU/ ml) Injections
3. Dapagliflozin Sodium (25 mg) Capsules
4. Dapagliflozin (5 mg) Tablets
5. Didanosine (200 mg) Capsules
6. Droperidol (1.25 mg/ ml) Injections
7. Eprosartan Mesylate (600 mg) Tablets
8. Goserelin Acetate (10.8 mg) Implants
9. Lanreotide Acetate (120 mg & 60 mg) Injections
10. Prothionamide (125 mg) Tablets

Reply

04 Sep 2021

Various FDFs needed in Iran [ENA11189]

A privately owned healthcare and pharmaceutical company focused on the development and commercialization of a portfolio of products and services within the areas of aesthetics, dermatology, medical food supplement and tech transfer is looking for suppliers of Various Finished Dosage Formulations for commercial purposes. The suppliers must support this enquiry with CTD Dossiers.
1. Alteplase (10 mg & 20 mg) Injections
2. Artemether (40 mg) Capsules
3. Artemether (80 mg) Injections
4. Bedaquiline Fumarate (100 mg) Tablets
5. Calfactant (100 mg) Tablets
6. Carbetocin (400 mg) Extended Release Tablets
7. Choriogonadotropin Alfa (4 g) Powder for Suspension
8. Corifollitropin Alfa (200 mcg/ ml) Injections
9. Corticotropin (300 mcg/ ml & 40 U/ ml) Injections
10. Cycloserine (1 g) Injections

Reply

23 Aug 2021